
Digital health stakeholders - including developers, policymakers, payers, and providers - are actively shaping and accelerating the adoption of digital health solutions, according to a new report from IQVIA.
Driven by the promise these tools offer to optimize care and reduce costs, as well as recent commercial challenges facing the sector, they are rethinking how they evaluate, approve, reimburse, and bring digital technologies to market.
The report examines the strategies each stakeholder is taking in a rapidly evolving landscape and address barriers to adoption. Developers that have struggled to scale their solutions are now diversifying their business models, consolidating to lead in specific segments, and are building broader solutions that better address stakeholder needs. Policymakers are refining national approval pathways and technology assessment criteria, while payers are expanding reimbursement to a wider range of digital solutions.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze